| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 306 |
| 1 | DEXAMETHASONE | 256 |
| 2 | DEXAMETHASONE 1.5 MG | 254 |
| 3 | CYCLOPHOSPHAMIDE | 253 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 253 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 253 |
| 6 | METHOTREXATE SODIUM | 232 |
| 7 | METHOTREXATE | 216 |
| 8 | BEVACIZUMAB | 195 |
| 9 | RIVAROXABAN | 194 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADENINE | 2 | 0.0408 |
| 1 | MATICO, SARSAPARILLA (SMILAX REGELII), THUJA OCCIDENTALIS, UNCARIA TOMENTOSA, PHYLLANTHUS NIRURI, POLYGONUM CUSPIDATUM | 2 | 0.0278 |
| 2 | DAUNORUBICIN HYDROCHLORIDE | 35 | 0.0212 |
| 3 | PEGASPARGASE | 100 | 0.0081 |
| 4 | BEXAROTENE | 9 | 0.0068 |
| 5 | BARICITINIB | 19 | 0.0062 |
| 6 | MERCAPTOPURINE | 96 | 0.0055 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 44 | 0.0053 |
| 8 | AMINOCAPROIC ACID | 4 | 0.0050 |
| 9 | COAGULATION FACTOR VIIA (RECOMBINANT) | 13 | 0.0048 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 662 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 338 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 322 |
| 3 | Alkylating Drug [EPC] | 293 |
| 4 | Platinum-based Drug [EPC] | 268 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 241 |
| 6 | Factor Xa Inhibitor [EPC] | 219 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 202 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 198 |
| 9 | Thalidomide Analog [EPC] | 174 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Asparagine-specific Enzyme [EPC] | 100 | 0.0074 |
| 1 | Sclerosing Agent [EPC] | 2 | 0.0044 |
| 2 | Anti-coagulant [EPC] | 9 | 0.0024 |
| 3 | Topoisomerase Inhibitor [EPC] | 151 | 0.0020 |
| 4 | Osmotic Diuretic [EPC] | 10 | 0.0019 |
| 5 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 4 | 0.0018 |
| 6 | Antifibrinolytic Agent [EPC] | 17 | 0.0017 |
| 7 | Thrombopoietin Receptor Agonist [EPC] | 26 | 0.0017 |
| 8 | Parenteral Iron Replacement [EPC] | 23 | 0.0017 |
| 9 | Non-Standardized Pollen Allergenic Extract [EPC] | 1 | 0.0016 |